My most viewed share in 2022 is $TransMedics Group, Inc.(TMDX)$ . It is also my most profitable trade in 2022. TransMedics' revenue jumped 378% year over year in the third quarter, driven by commercial sales of its heart and liver transport systems. TransMedics guided for full-year revenue growth of at least 164%, and its impressive 71% gross margins suggest the $1.9 billion company could be a cash cow for investors as it grows. TransMedics could also potentially be an attractive acquisition target for a larger health care company. TMDX stock went up 222.1% in 2022.
My top friend in Tiger community is @AhGong .
Modify on 2023-01-10 21:23
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- Samlunch·2023-01-10Good find thanksLikeReport
- Juliasheng·2023-01-15[微笑]LikeReport
- Tiger 88·2023-01-10👍LikeReport
- Humble_Teoh·2023-01-10OoLikeReport
- Cryotan·2023-01-10NiceLikeReport
- Kinoshita·2023-01-10HuatLikeReport
- Ooi·2023-01-10OkLikeReport
- Rcsl·2023-01-10👍LikeReport